| Vaccination strategies to combat novel corona virus SARS-CoV-2 SC Pandey, V Pande, D Sati, S Upreti, M Samant Life sciences 256, 117956, 2020 | 145 | 2020 |
| Microbial Interventions in Bioremediation of Heavy Metal Contaminants in Agroecosystem V Pande, SC Pandey, D Sati, P Bhatt, M Samant Frontiers in Microbiology, 1417, 2022 | 110 | 2022 |
| Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral … M Samant, R Gupta, S Kumari, P Misra, P Khare, PK Kushawaha, ... The Journal of Immunology 183 (1), 470-479, 2009 | 88 | 2009 |
| In vitro and in vivo leishmanicidal activity of Dysoxylum binectariferum and its fractions against Leishmania donovani V Lakshmi, K Pandey, A Kapil, N Singh, M Samant, A Dube Phytomedicine 14 (1), 36-42, 2007 | 87 | 2007 |
| Bioremediation: an emerging effective approach towards environment restoration V Pande, SC Pandey, D Sati, V Pande, M Samant Environmental Sustainability 3, 91-103, 2020 | 86 | 2020 |
| Role of cytokines in experimental and human visceral leishmaniasis M Samant, U Sahu, SC Pandey, P Khare Frontiers in cellular and infection microbiology 11, 624009, 2021 | 67 | 2021 |
| Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection P Khare, U Sahu, SC Pandey, M Samant Virus research 290, 198169, 2020 | 66 | 2020 |
| Antileishmanial activity mediated by apoptosis and structure-based target study of peganine hydrochloride dihydrate: an approach for rational drug design P Misra, T Khaliq, A Dixit, S SenGupta, M Samant, S Kumari, A Kumar, ... Journal of antimicrobial chemotherapy 62 (5), 998-1002, 2008 | 63 | 2008 |
| Recent advances in PGPR and molecular mechanisms involved in drought stress resistance D Sati, V Pande, SC Pandey, M Samant Journal of Soil Science and Plant Nutrition 23 (1), 106-124, 2023 | 62 | 2023 |
| Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis S Kumari, M Samant, P Misra, P Khare, B Sisodia, AK Shasany, A Dube Vaccine 26 (45), 5700-5711, 2008 | 62 | 2008 |
| DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control A Kumar, M Samant Parasite immunology 38 (5), 273-281, 2016 | 59 | 2016 |
| Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis S Kumari, M Samant, P Khare, P Misra, S Dutta, BK Kolli, S Sharma, ... European journal of immunology 39 (1), 178-191, 2009 | 52 | 2009 |
| Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza … M Baz, M Samant, H Zekki, P Tribout-Jover, M Plante, AM Lanteigne, ... Clinical and Vaccine Immunology 19 (2), 209-218, 2012 | 51 | 2012 |
| Evaluation of antileishmanial potential of Tinospora sinensis against experimental visceral leishmaniasis N Singh, A Kumar, P Gupta, K Chand, M Samant, R Maurya, A Dube Parasitology research 102, 561-565, 2008 | 51 | 2008 |
| Interleukin‐17—A multifaceted cytokine in viral infections U Sahu, D Biswas, VK Prajapati, AK Singh, M Samant, P Khare Journal of Cellular Physiology 236 (12), 8000-8019, 2021 | 48 | 2021 |
| Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite … R Gupta, PK Kushawaha, M Samant, AK Jaiswal, RK Baharia, A Dube Journal of antimicrobial chemotherapy 67 (2), 440-443, 2012 | 46 | 2012 |
| Slow pace of antileishmanial drug development A Kumar, SC Pandey, M Samant Parasitology Open 4, e4, 2018 | 43 | 2018 |
| DDX3 DEAD-box RNA helicase plays a central role in mitochondrial protein quality control in Leishmania PK Padmanabhan, O Zghidi-Abouzid, M Samant, C Dumas, BG Aguiar, ... Cell death & disease 7 (10), e2406-e2406, 2016 | 38 | 2016 |
| Discovery of novel vaccine candidates and drug targets against visceral leishmaniasis using proteomics and transcriptomics S Kumari, A Kumar, M Samant, N Singh, A Dube Current Drug Targets 9 (11), 938-947, 2008 | 37 | 2008 |
| Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani M Samant, AA Sahasrabuddhe, N Singh, SK Gupta, S Sundar, A Dube Parasitology 134 (9), 1175-1184, 2007 | 35 | 2007 |
Satish Chandra Pandey, Ph.D.Center for Microbial Pathogenesis, Nationwide Children's Hospital, Columbus, Ohio, USA在 nationwidechildrens.org 的电子邮件经过验证
